Results 131 to 140 of about 5,450,952 (343)
Certification and registration of death-the urgent need for improvement [PDF]
James Robert Kaye
openalex +1 more source
Global causes of maternal death: a WHO systematic analysis.
L. Say+9 more
semanticscholar +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
The Black Death of 1348 and 1349. [PDF]
Ellen A. McArthur, Abbot Gasquet
openalex +1 more source
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
S. Dixon+11 more
semanticscholar +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source
Carcinoma of the Maxillary Antrum; Moure's Operation of Lateral Rhinotomy; Recurrence; Death
Irwin Moore
openalex +1 more source
Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?
Chen‐xi Li, Zhong‐cheng Gong
wiley +1 more source
Background Genetic diagnostics support the diagnosis of hereditary arrhythmogenic diseases, but variants of uncertain significance (VUS) complicate matters, emphasising the need for regular reassessment.
Sarah Martin+4 more
doaj +1 more source